Company intelligence / Profile preview

Optimal Tracers

Sacramento, California, United States

Ownership: Private
Development stage: Other

Overview

Optimal Tracers is a radiochemistry service provider that develops, manufactures, and supplies clinical and preclinical radiotracers for use in clinical trials and research, serving academic, biotech, and pharma clients, as well as offering process development and regulatory support. It was acquired by Telix Pharmaceuticals in November 2022 and is now a strategic component of Telix’s radiopharmaceutical manufacturing and development capabilities.

Modalities: Radiopharmaceutical
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Optimal Tracers.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Optimal Tracers.

Explore the full profile